Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD276 ( clone NJI64D3). We employs the Retrovirus (SV40-GFP-TFIIB-XbaI) vector components and the SynExpress system of the exons Knockout/Balancing feedback for a robust and sustained response against cancers.
Host
Human
Target
CD276
Clone
NJI64D3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
SV40
Effector Gene
TFIIB
Insertion Sites
XbaI
Gene Modification
Knockout
Modification Domain
Exons
Carrier Type
Retrovirus
Transformation Accuracy
0.91
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.